Free Trial

Profound Medical (PROF) Stock Forecast & Price Target

Profound Medical logo
$7.69 -0.14 (-1.79%)
(As of 11/20/2024 ET)

Profound Medical - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
4

Based on 4 Wall Street analysts who have issued ratings for Profound Medical in the last 12 months, the stock has a consensus rating of "Buy." Out of the 4 analysts, 3 have given a buy rating, and 1 has given a strong buy rating for PROF.

Consensus Price Target

$13.75
78.80% Upside
According to the 4 analysts' twelve-month price targets for Profound Medical, the average price target is $13.75. The highest price target for PROF is $16.50, while the lowest price target for PROF is $12.00. The average price target represents a forecasted upside of 78.80% from the current price of $7.69.
Get the Latest News and Ratings for PROF and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Profound Medical and its competitors.

Sign Up

PROF Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
1 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
0 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$13.75$13.75$15.31$14.67
Forecasted Upside78.80% Upside84.81% Upside69.57% Upside42.63% Upside
Consensus Rating
Buy
Buy
Buy
Buy

PROF Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PROF Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Profound Medical Stock vs. The Competition

TypeProfound MedicalMedical CompaniesS&P 500
Consensus Rating Score
3.25
2.80
2.50
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside78.80% Upside26,931.56% Upside9.83% Upside
News Sentiment Rating
Positive News

See Recent PROF News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/9/2024Raymond James
4 of 5 stars
M. Freeman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/23/2024Lake Street Capital
3 of 5 stars
 Initiated CoverageBuy$16.50+62.08%
7/16/2024Stifel Nicolaus
4 of 5 stars
 UpgradeHold ➝ Buy$9.00 ➝ $12.00+31.15%
1/4/2024Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$14.25 ➝ $12.75+66.02%
3/21/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$5.50 ➝ $10.00-1.57%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:00 AM ET.


PROF Forecast - Frequently Asked Questions

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Profound Medical is $13.75, with a high forecast of $16.50 and a low forecast of $12.00.

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Profound Medical in the last year. There are currently 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" PROF shares.

According to analysts, Profound Medical's stock has a predicted upside of 78.80% based on their 12-month stock forecasts.

Over the previous 90 days, Profound Medical's stock had 1 upgrade by analysts.

Profound Medical has been rated by research analysts at Raymond James in the past 90 days.

Analysts like Profound Medical more than other "medical" companies. The consensus rating for Profound Medical is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how PROF compares to other companies.


This page (NASDAQ:PROF) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners